Cargando…

Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data

BACKGROUND: Global withdrawal of serotype-2 oral poliovirus vaccine (OPV2) took place in April 2016. This marked a milestone in global polio eradication and was a public health intervention of unprecedented scale, affecting 155 countries. Achieving high levels of serotype-2 population immunity befor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pons-Salort, Margarita, Molodecky, Natalie A., O’Reilly, Kathleen M., Wadood, Mufti Zubair, Safdar, Rana M., Etsano, Andrew, Vaz, Rui Gama, Jafari, Hamid, Grassly, Nicholas C., Blake, Isobel M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049753/ https://www.ncbi.nlm.nih.gov/pubmed/27701425 http://dx.doi.org/10.1371/journal.pmed.1002140

Ejemplares similares

Risk factors and short-term projections for serotype-1 poliomyelitis incidence in Pakistan: A spatiotemporal analysis
por: Molodecky, Natalie A., et al.
Publicado: (2017)

Type 2 poliovirus detection after global withdrawal of trivalent oral vaccine
por: Blake, Isobel M., et al.
Publicado: (2018)

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame
por: Parker, Edward PK, et al.
Publicado: (2015)

Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014–April 2016
por: Shirreff, George, et al.
Publicado: (2017)

Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014–2017
por: Grassly, Nicholas C., et al.
Publicado: (2018)

Population sensitivity of acute flaccid paralysis and environmental surveillance for serotype 1 poliovirus in Pakistan: an observational study
por: O’Reilly, Kathleen M., et al.
Publicado: (2018)

An assessment of the geographical risks of wild and vaccine-derived poliomyelitis outbreaks in Africa and Asia
por: O’Reilly, Kathleen M., et al.
Publicado: (2017)

Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic()
por: Molodecky, Natalia A, et al.
Publicado: (2023)

Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame
por: Pons-Salort, Margarita, et al.
Publicado: (2016)

A New Method for Estimating the Coverage of Mass Vaccination Campaigns Against Poliomyelitis From Surveillance Data
por: O'Reilly, K. M., et al.
Publicado: (2015)

The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001–11: a retrospective analysis
por: O'Reilly, Kathleen M, et al.
Publicado: (2012)

The Origins and Risk Factors for Serotype-2 Vaccine-Derived Poliovirus Emergences in Africa During 2016–2019
por: Gray, Elizabeth J, et al.
Publicado: (2023)

Routine immunization in Pakistan: comparison of multiple data sources and identification of factors associated with vaccination
por: Imran, Hafsa, et al.
Publicado: (2018)

Progress Toward Poliomyelitis Eradication — Afghanistan, January 2019–July 2020
por: Martinez, Maureen, et al.
Publicado: (2020)

Progress Toward Poliomyelitis Eradication ― Afghanistan, January 2020–November 2021
por: Sadigh, Katrin S., et al.
Publicado: (2022)

Progress Toward Poliomyelitis Eradication ― Afghanistan, January 2021–September 2022
por: Mohamed, Abdinoor, et al.
Publicado: (2022)

Progress Toward Poliomyelitis Eradication — Afghanistan, January 2022–June 2023
por: Bjork, Adam, et al.
Publicado: (2023)

Public Health Innovations on the Way to Interruption of Poliovirus Transmission in Nigeria
por: Vaz, Rui G., et al.
Publicado: (2016)

Progress Toward Poliomyelitis Eradication — Afghanistan, January 2016–June 2017
por: Martinez, Maureen, et al.
Publicado: (2017)

Faster Detection of Poliomyelitis Outbreaks to Support Polio Eradication
por: Blake, Isobel M., et al.
Publicado: (2016)

Progress Toward Poliomyelitis Eradication — Pakistan, January 2021–July 2022
por: Mbaeyi, Chukwuma, et al.
Publicado: (2022)

Progress Toward Poliomyelitis Eradication — Pakistan, January 2022–June 2023
por: Mbaeyi, Chukwuma, et al.
Publicado: (2023)

The final stages of the global eradication of poliomyelitis
por: Grassly, Nicholas C.
Publicado: (2013)

Progress Toward Poliomyelitis Eradication — Pakistan, January 2016–September 2017
por: Elhamidi, Youness, et al.
Publicado: (2017)

Risk factors for the spread of vaccine-derived type 2 polioviruses after global withdrawal of trivalent oral poliovirus vaccine and the effects of outbreak responses with monovalent vaccine: a retrospective analysis of surveillance data for 51 countries in Africa
por: Cooper, Laura V, et al.
Publicado: (2022)

Fractional-Dose Inactivated Poliovirus Vaccine Campaign — Sindh Province, Pakistan, 2016
por: Pervaiz, Aslam, et al.
Publicado: (2017)

Surveillance optimisation to detect poliovirus in the pre-eradication era: a modelling study of England and Wales
por: O'Reilly, K. M., et al.
Publicado: (2020)

A Statistical Model of the International Spread of Wild Poliovirus in Africa Used to Predict and Prevent Outbreaks
por: O'Reilly, Kathleen M., et al.
Publicado: (2011)

Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge
por: Hird, Thomas R., et al.
Publicado: (2012)

The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
por: Thompson, Kimberly M., et al.
Publicado: (2015)

Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes
por: Thompson, Kimberly M., et al.
Publicado: (2017)

Mouse neuropathogenic poliovirus strains cause damage in the central nervous system distinct from poliomyelitis
por: Gromeier, Matthias, et al.
Publicado: (1995)

The role of a genetically stable, novel oral type 2 poliovirus vaccine in the poliomyelitis endgame
por: Costa Clemens, Sue Ann, et al.
Publicado: (2023)

Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
por: Duintjer Tebbens, Radboud J., et al.
Publicado: (2016)

I. Foreword-With a Review of the Past Experiences of the Yale Poliomyelitis Study Unit with Oral Poliovirus Vaccines
por: Paul, John R.
Publicado: (1962)

Introduction of Inactivated Poliovirus Vaccine and Impact on Vaccine-Associated Paralytic Poliomyelitis — Beijing, China, 2014–2016
por: Zhao, Dan, et al.
Publicado: (2017)

Nucleotide variation in Sabin type 3 poliovirus from an Albanian infant with agammaglobulinemia and vaccine associated poliomyelitis
por: Foiadelli, Thomas, et al.
Publicado: (2016)

Progress Toward Poliomyelitis Eradication — Afghanistan and Pakistan, January 2013–August 2014
por: Farag, Noha H., et al.
Publicado: (2014)

The role of genetic sequencing and analysis in the polio eradication programme
por: Jorgensen, David, et al.
Publicado: (2020)

Virologic Monitoring of Poliovirus Type 2 after Oral Poliovirus Vaccine Type 2 Withdrawal in April 2016 — Worldwide, 2016–2017
por: Diop, Ousmane M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7lp7lqi1gmu4l2a4p3848bnsbd